Parents Administer GLP-1 Medications to Children for Obesity and Related Health Issues
Parents in the U.S. are increasingly opting to administer GLP-1 medications, such as Wegovy and Zepbound, to their children to address obesity and associated health conditions. This trend is emerging despite the drugs traditionally being reserved for adults. For instance, Jenna Ceriani put her son on a GLP-1 after he was removed from a football league due to his weight and struggled with sleep apnea. Similarly, Angela, a mother from Pennsylvania, chose GLP-1s for her daughter who experienced compulsive thoughts about food and metabolic dysfunction. Pediatric obesity specialists like Dr. Shaista Safder of Orlando Health support this approach, viewing GLP-1s as a crucial intervention for children with comorbidities like fatty liver disease, aiming to prevent irreversible damage. Dr. Anna Trepekli, co-founder of Hey Nouri, a virtual pediatric obesity clinic, frames GLP-1s as a treatment for a medical condition rather than solely weight loss, creating an opportunity for children to develop healthier habits. Th...